Cited by 661Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction ResearchCardiac Health and Mental Health

The DOI matches its Crossref record, with a small difference in title or year; 36 of the 36 references it cites were found in a registry or an index.

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update: A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology

Open access

Smith, Sidney C., Blair, Steven N., Bonow, Robert O., Brass, Lawrence M., Cerqueira, Manuel D., Dracup, Kathleen, Fuster, Valentin, Gotto, Antonio, Grundy, Scott M., Miller, Nancy Houston, Jacobs, Alice, Jones, Daniel, Krauss, Ronald M., Mosca, Lori, Ockene, Ira, Pasternak, Richard C., Pearson, Thomas, Pfeffer, Marc A., Starke, Rodman D., Taubert, Kathryn A.·2001·Circulation

DOI 10.1161/hc3801.097475

Open this paper in CoChat — free account Open PDF

Abstract

Since the original publication (in 1995) of the American Heart Association (AHA) consensus statement on secondary prevention, which was endorsed by the American College of Cardiology (ACC), important evidence from clinical trials has emerged that further supports the merits of aggressive risk reduction therapies for patients with atherosclerotic cardiovascular disease. As noted in that statement, aggressive risk factor management clearly improves patient survival, reduces recurrent events and the need for interventional procedures, and improves the quality of life for these patients. The compelling evidence from some recent clinical trials was the impetus to revise the 1995 guidelines.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/hc3801.097475

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Self-citation
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Self-citation
ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,475
Self-citation
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 4,204
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638

Show all 36 references

Research works printed but not linked: 4

10.1161/circ.102.10.1193 · DOI
10.1161/circ.100.10.1132 · DOI
10.1161/circ.104.4.499 · DOI
10.1161/circ.90.6.7994868 · DOI

Sorted by citations

Items 201–300 of 661

The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient
Ong, H. T. (2005) · QJM · doi:10.1093/qjmed/hci093 · Cited by 49
Pericardial disease: what the general cardiologist needs to know
Ivens, E., Munt, B. I., & Moss, R. (2007) · Heart · doi:10.1136/hrt.2005.086587 · Cited by 49
Multifactor Cardiovascular Disease Risk Reduction in Medically Underserved, High-Risk Patients
Haskell, W. L., Berra, K., Arias, E., Christopherson, D. J., Clark, A., George, J., Hyde, S., Klieman, L., & Myll, J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.049 · Cited by 47
Metabolomics and ischaemic heart disease
Rasmiena, A. A., Ng, T. W., & Meikle, P. J. (2012) · Clinical Science · doi:10.1042/cs20120268 · Cited by 48
Adherence to Clinical Practice Guidelines for 7 Chronic Conditions in Long-term-Care Patients Who Received Pharmacist Disease Management Services Versus Traditional Drug Regimen Review
Horning, K. K., Hoehns, J. D., & Doucette, W. R. (2007) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2007.13.1.28 · Cited by 48
Risk factors and in-hospital outcome of acute ST segment elevation myocardial infarction in young Bangladeshi adults
Karim, M. A., Majumder, A. A. S., Islam, K. Q., Alam, M. B., Paul, M. L., Islam, M. S., Chowdhury, K. N., & Islam, S. M. S. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0069-2 · Cited by 48
Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary Prevention Programs
King, M. L., Williams, M. A., Fletcher, G. F., Gordon, N. F., Gulanick, M., King, C. N., Leon, A. S., Levine, B. D., Costa, F., & WENGER, N. K. (2005) · Circulation · doi:10.1161/circulationaha.105.170333 · Cited by 47
Predicting intracranial lesions by antiplatelet agents in subjects with mild head injury
Fabbri, A., Servadei, F., Marchesini, G., Stein, S. C., & Vandelli, A. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.197467 · Cited by 46
Dietitian Services Are Associated with Improved Patient Outcomes and the MEDFICTS Dietary Assessment Questionnaire Is a Suitable Outcome Measure in Cardiac Rehabilitation
Holmes, A. L., Sanderson, B., Maisiak, R., Brown, A., & Bittner, V. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2005.08.001 · Cited by 46
Effects of a Contemporary, Exercise-Based Rehabilitation and Cardiovascular Risk-Reduction Program on Coronary Patients With Abnormal Baseline Risk Factors
Franklin, B. A., Bonzheim, K. A., Warren, J., Haapaniemi, S., Byl, N. E., & Gordon, N. F. (2002) · CHEST Journal · doi:10.1378/chest.122.1.338 · Cited by 46
The Role of Depression on Treatment Adherence in Patients with Heart Failure–a Systematic Review of the Literature
Poletti, V., Pagnini, F., Banfi, P. I., & Volpato, E. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01815-0 · Cited by 45
Cardioprotection: The Role of β‐Blocker Therapy
Egan, B. M., Basile, J., CHILTON, R. J., & Cohen, J. D. (2005) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2005.04486.x · Cited by 45
Cardiovascular risk factors in the urban Mexican population: The FRIMEX study
Meaney, E., Lara-Esqueda, A., Ceballos-Reyes, G. M., Asbun, J., Vela, A., Martínez-Marroquín, Y., López, V., Meaney, A., de la Cabada-Tamez, E., Velázquez-Monroy, Ó., et al. (2007) · Public Health · doi:10.1016/j.puhe.2006.11.008 · Cited by 45
Prescription Prevalence and Continuing Medication Use for Secondary Prevention After Myocardial Infarction
Mangiapane, S., & Busse, R. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0856 · Cited by 44
Effects of exercise and cardiac rehabilitation on cardiovascular outcomes
Ades, P. A., Green, N. M., & Coello, C. E. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00056-0 · Cited by 44
Short-Term Effects of Sleeve Gastrectomy and Caloric Restriction on Blood Pressure in Diet-Induced Obese Rats
Rodrı́guez, A., Becerril, S., Valentí, V., Moncada, R., Méndez-Giménez, L., Ramírez, B., Lancha, A., Martín, M., Burrell, M. A., Catalán, V., et al. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0702-4 · Cited by 45
Design, synthesis and hypolipidemic activity of novel 2-(naphthalen-2-yloxy)propionic acid derivatives as desmethyl fibrate analogs
Idrees, G. A., Aly, O. M., Abuo‐Rahma, G. E. A., & Radwan, M. F. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.04.026 · Cited by 43
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
Kulik, A., May, M. R. L., Wells, G. A., Mesana, T. G., & Ruel, M. (2005) · Current Controlled Trials in Cardiovascular Medicine · doi:10.1186/1468-6708-6-15 · Cited by 43
Clinical Approach to Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease
Rennard, S. I. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200410-051sf · Cited by 42
A “poly-portfolio” for secondary prevention: A strategy to reduce subsequent events by up to 97% over five years
Robinson, J. G., & Maheshwari, N. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.09.036 · Cited by 42
n−3 long‐chain FA decrease serum levels of TG and remnant‐like particle‐cholesterol in humans
Hamazaki, K., Itomura, M., Huan, M., Nishizawa, H., Watanabe, S., Hamazaki, T., Sawazaki, S., TERASAWA, K., Nakajima, S., Terano, T., et al. (2003) · Lipids · doi:10.1007/s11745-003-1069-x · Cited by 41
Underutilization of Aspirin, Beta Blockers, Angiotensin-Converting Enzyme Inhibitors, and Lipid-Lowering Drugs and Overutilization of Calcium Channel Blockers in Older Persons With Coronary Artery Disease in an Academic Nursing Home
Ghosh, S., Ziesmer, V., & Aronow, W. S. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.6.m398 · Cited by 41
Gender Differences in Aspirin use Among Adults With Coronary Heart Disease in the United States
Opotowsky, A. R., McWilliams, J. M., & Cannon, C. P. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0116-5 · Cited by 41
Beta-blockers for preventing stroke recurrence
Lima, L. G. D., Saconato, H., Atallah, Á. N., & da Silva, E. M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007890.pub3 · Cited by 39
Exercise training for patients with cardiovascular disease
Casillas, J.-M., Grémeaux, V., Damak, S., Feki, A., & Pérennou, D. A. (2007) · Annales de Réadaptation et de Médecine Physique · doi:10.1016/j.annrmp.2007.03.007 · Cited by 43
Impact of Lipid-Lowering Therapy With Pitavastatin, a New HMG-CoA Reductase Inhibitor, on Regression of Coronary Atherosclerotic Plaque A 3-Dimensional Intravascular Ultrasound Study
Takashima, H., Ozaki, Y., Yasukawa, T., Waseda, K., Asai, K., Wakita, Y., Kuroda, Y., Kosaka, T., Kuhara, Y., & Ito, T. (2007) · Circulation Journal · doi:10.1253/circj.71.1678 · Cited by 39
Long-Term Disease Management of Patients With Coronary Disease by Cardiac Rehabilitation Program Staff
Squires, R. W., Montero-Gómez, A., Allison, T. G., & Thomas, R. J. (2008) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/01.hcr.0000320068.35728.12 · Cited by 39
Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial
Goff, D. C., Gu, L., Cantley, L. K., Sheedy, D. J., & Cohen, S. J. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00522-2 · Cited by 39
Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
Huang, Y. L., Lai, C., Wang, Y., Wang, C., Wang, J., Wang, H., Yu, C., & Chen, L. (2017) · International Journal of COPD · doi:10.2147/copd.s145913 · Cited by 38
Utilization of lipid-lowering drugs in elderly persons with increased serum low-density lipoprotein cholesterol associated with coronary artery disease, symptomatic peripheral arterial disease, prior stroke, or diabetes mellitus before and after an educational program on dyslipidemia treatment.
Ghosh, S., & Aronow, W. (2003) · The journals of gerontology. Series A, Biological sciences and medical sciences · doi:10.1093/gerona/58.5.m432 · Cited by 38
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study
Colquhoun, D. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.03.013 · Cited by 37
Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates
Baessler, A., Fischer, M., Huf, V. I., Mell, S., Hengstenberg, C., Mayer, B., Holmer, S. R., Riegger, G. A. J., & Schunkert, H. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.03.053 · Cited by 38
Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: Observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS–TIMI 16) trial
Smith, C. S., Cannon, C. P., McCabe, C. H., Murphy, S. A., Bentley, J., & D, E. B. M. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.06.033 · Cited by 38
Interventions to improve guideline compliance following coronary artery bypass grafting
Yam, F. K., Akers, W. S., Ferraris, V. A., Smith, K. M., Ramaiah, C., Camp, P. C., & Flynn, J. D. (2006) · Surgery · doi:10.1016/j.surg.2006.05.014 · Cited by 36
Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424
Shaw, L. J., Heller, G. V., Casperson, P. R., Miranda-Peats, R., Slomka, P. J., Friedman, J. D., Hayes, S. W., Schwartz, R. G., Weintraub, W. S., Maron, D. J., et al. (2006) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2006.06.134 · Cited by 37
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2005) · Cited by 37
Comment on the Reports of Over-estimation of ASCVD Risk Using the 2013 AHA/ACC Risk Equation
Muntner, P., Safford, M. M., Cushman, M., & Howard, G. (2013) · Circulation · doi:10.1161/circulationaha.113.007648 · Cited by 37
Physician diagnosis of overweight status predicts attempted and successful weight loss in patients with cardiovascular disease and central obesity
Singh, S., Somers, V. K., Clark, M. M., Vickers, K. S., Hensrud, D. D., Korenfeld, Y., & López-Jiménez, F. A. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.07.023 · Cited by 36
Diet and physical activity of U.S. adults with heart disease following preventive advice
Wofford, T. S., Greenlund, K. J., Croft, J. B., & Labarthe, D. R. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.06.013 · Cited by 36
Prevention and Control of Coronary Heart Disease and Stroke—Nomenclature for Prevention Approaches in Public Health
Mensah, G. A., Dietz, W. H., Harris, V. B., Henson, R. M., Labarthe, D. R., Vinicor, F., & Wechsler, H. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.07.035 · Cited by 36
Significance of High Density Lipoprotein-Cholesterol in Cardiovascular Risk Prevention
Ascaso, J. F., ndez-Cruz, A. F., Santos, P. G. L., Hernández‐Mijares, A., Mangas, A., n, J. M., Pallardo, L. F., Pedro‐Botet, J., Pérez‐Jiménez, F., a, G. P., et al. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404050-00003 · Cited by 36
Does farm worker health vary between localised and globalised food supply systems?
Cross, P., Edwards, R. T., Opondo, M., Nyeko, P., & Edwards‐Jones, G. (2009) · Environment International · doi:10.1016/j.envint.2009.04.009 · Cited by 34
Effective strategies for long-term statin use
Fonarow, G. C., & Watson, K. E. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00506-x · Cited by 33
Activity and Heart Rate-based Measures for Outpatient Cardiac Rehabilitation
Sarela, A., & Bidargaddi, N. P. (2008) · Methods of Information in Medicine · doi:10.3414/me9112 · Cited by 33
Management of the patient with diabetes mellitus and myocardial infarction: clinical trials update
Klein, L., & Gheorghiade, M. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.020 · Cited by 33
Predictors of weight change in overweight patients with myocardial infarction
Fadl, Y. Y., Krumholz, H. M., Kosiborod, M., Masoudi, F. A., Peterson, P. N., Reid, K. J., Weintraub, W. S., Buchanan, D. M., & Spertus, J. A. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.06.006 · Cited by 32
The VIOXX in prostate cancer prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups
van Adelsberg, J., Gann, P. H., Ko, A. T., Damber, J. ‐., Logothetis, C. J., Marberger, M., Schmitz‐Dräger, B. J., Tubaro, A., Harms, C. J., & Roehrborn, C. G. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x219526 · Cited by 32
Designing a Sustainable National Registry for Stroke Quality Improvement
Schwamm, L. H., Reeves, M. J., & Frankel, M. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.08.013 · Cited by 32
Conundrums in the Combined Use of Anticoagulants and Antiplatelet Drugs
Schneider, D. J., & Sobel, B. E. (2007) · Circulation · doi:10.1161/circulationaha.106.655910 · Cited by 31
Prevalence and Predictors of Angina Pectoris One Month After Myocardial Infarction
Spertus, J. A., Dawson, J., Masoudi, F. A., Krumholz, H. M., Reid, K. J., Peterson, E. D., & Rumsfeld, J. S. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.099 · Cited by 31
Prevention Conference VI: Diabetes and Cardiovascular Disease
Bonow, R. O., Mitch, W. E., Nesto, R. W., O’Gara, P. T., Becker, R. C., Clark, L. T., Hunt, S. A., Jialal, I., Lipshultz, S. E., & Loh, E. (2002) · Circulation · doi:10.1161/01.cir.0000013956.95796.74 · Cited by 31
Self-citation
Challenges and opportunities in quantifying the quality of care for acute myocardial infarction
Spertus, J. A., Radford, M. J., Every, N. R., Ellerbeck, E. F., Peterson, E. D., & Krumholz, H. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00415-7 · Cited by 31
Missed opportunities for the secondary prevention of cardiovascular disease in Canada
Hackam, D. G., Leiter, L. A., Yan, A. T.-K., Yan, R. T., Mendelsohn, A. A., Tan, M., Zavodni, L., Chen, R., Tsang, J. L. Y., Kundi, A., et al. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70882-6 · Cited by 30
Primary care physician smoking screening and counseling for patients with chronic disease
Nelson, K. E., Hersh, A. L., Nkoy, F. L., Maselli, J. H., Srivastava, R., & Cabana, M. D. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.11.010 · Cited by 30
Control de factores de riesgo coronario en prevención secundaria: estudio PRESENAP
Iparraguirre, S. T., Rodríguez, I. L., Prieto, J. M. M., López, B. S., Morató, M. T. M., Taboada, M. T., Lahoz, C., Martín-Jadraque, L., & Monteiro, B. (2006) · Medicina Clínica · doi:10.1157/13095812 · Cited by 30
Implementing a Pathway for the Management of Acute Coronary Syndrome Leads to Improved Compliance With Guidelines and a Decrease in Angina Symptoms
Aziz, E. F., Javed, F., Pulimi, S., Pratap, B., Zunino, M. E. D. B., Tormey, D., Hong, M. K., & Herzog, E. (2011) · Journal for Healthcare Quality · doi:10.1111/j.1945-1474.2011.00145.x · Cited by 29
2001 National Cholesterol Education Program (NCEP) Guidelines on the Detection, Evaluation and Treatment of Elevated Cholesterol in Adults: Adult Treatment Panel III (ATP III)
Pasternak, R. C. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00670-0 · Cited by 29
Self-citation
Are recent statin recommendations to employ fixed doses and abandon targets effective for treatment of hypercholesterolaemia? Investigation based on number needed to treat
Soran, H., Adam, S., & Durrington, P. N. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316667785 · Cited by 29
Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival
Bunch, T. J., Hammill, S. C., & White, R. D. (2005) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61532-2 · Cited by 29
Effects of Enhanced External Counterpulsation on Carotid Circulation in Patients with Coronary Artery Disease
Levenson, J. A., Simon, A. C., Mégnien, J. L., Chironi, G. N., Gariépy, J., Pernollet, M. G., Craiem, D. O., & Iliou, M. C. (2006) · Cardiology · doi:10.1159/000095949 · Cited by 27
Coronary Heart Disease Prevention and Lifestyle Interventions
Chyun, D. A., Amend, A., Newlin, K., Langerman, S., & Melkus, G. D. (2003) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200309000-00009 · Cited by 29
Coronary artery disease and prevention of heart failure
Klein, L., & Gheorghiade, M. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.03.002 · Cited by 31
Illness cognition as a predictor of exercise habits and participation in cardiac prevention and rehabilitation programs after acute coronary syndrome
Reges, O., Vilchinsky, N., Leibowitz, M., Khaskia, A., Mosseri, M., & Kark, J. D. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-956 · Cited by 28
Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observations
Duprez, D. A., Florea, N. D., Zhong, W., Grandits, G. A., Hawthorne, C. K., Hoke, L., & Cohn, J. N. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.05.001 · Cited by 28
Beta-blocker therapy of cardiovascular diseases in patients with bronchial asthma or COPD: The pro viewpoint
Ashrafian, H., & Violaris, A. G. (2005) · Primary Care Respiratory Journal · doi:10.1016/j.pcrj.2005.06.005 · Cited by 28
Vascular surgery critical care: Perioperative cardiac optimization to improve survival
Venkataraman, R. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000231885.74567.4f · Cited by 28
Practical considerations of β-blockade in the management of the post–myocardial infarction patient
Fonarow, G. C. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.008 · Cited by 28
Secondary prevention after coronary bypass: the American Heart Association “Get with the Guidelines” program
Denton, T. A., Fonarow, G. C., LaBresh, K. A., & Trento, A. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)04885-3 · Cited by 28
Association of baseline sex hormone levels with baseline and longitudinal changes in waist-to-hip ratio: Multi-Ethnic Study of Atherosclerosis
Vaidya, D. M., Dobs, A. S., Gapstur, S. M., Golden, S. H., Cushman, M., Liu, K., & Ouyang, P. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.3 · Cited by 27
Long-Term Risk of Stroke in Myocardial Infarction Survivors
Sundbøll, J., Horváth–Puhó, E., Schmidt, M., Pedersen, L. H., Henderson, V. W., Bøtker, H. E., & Sørensen, H. T. (2016) · Stroke · doi:10.1161/strokeaha.116.013321 · Cited by 27
A multifaceted intervention according to the Audit Project Odense method improved secondary prevention of ischemic heart disease: a randomised controlled trial.
Søndergaard, J., Hansen, D., Aarslev, P. J., & Munck, A. (2006) · Family Practice · doi:10.1093/fampra/cmi090 · Cited by 33
Meeting AHA/ACC secondary prevention goals in a vascular surgery practice: An opportunity we cannot afford to miss
Kinikini, D. V., Sarfati, M. R., Mueller, M. T., & Kraiss, L. W. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.12.002 · Cited by 27
Recognition, diagnosis and management of obesity after myocardial infarction
López-Jiménez, F. A., Malinski, M. K., Gutt, M., Sierra‐Johnson, J., Aude, Y. W., Rimawi, A., Mego, P. A., Thomas, R. J., Allison, T. G., Kirby, B., et al. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802831 · Cited by 27
Process of care for carotid endarterectomy: Perioperative medical management
Stoner, M. C., & deFreitas, D. J. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.10.125 · Cited by 26
Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis
Tran‐Duy, A., Vanmolkot, F. H. M., Joore, M. A., Hoes, A. W., & Stehouwer, C. D. A. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12634 · Cited by 26
Explanatory models of coronary heart disease among South Asian immigrants
Tirodkar, M. A., Baker, D. W., Khurana, N. R., Makoul, G. T., Paracha, M. W., & Kandula, N. R. (2010) · Patient Education and Counseling · doi:10.1016/j.pec.2010.10.002 · Cited by 26
Wellness motivation in cardiac rehabilitation: The role of self‐knowledge in cardiovascular risk modification
Fleury, J., & Sedikides, C. (2007) · Research in Nursing & Health · doi:10.1002/nur.20225 · Cited by 26
Efficacy of Drug Therapy in the Secondary Prevention of Cardiovascular Disease and Stroke
Fletcher, G. F., Bufalino, V. J., Costa, F., Goldstein, L. B., Jones, D., Smaha, L. A., Smith, S. C., & Stone, N. J. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.02.001 · Cited by 27
Self-citation
Information given to postmenopausal women on coronary computed tomography may influence cardiac risk reduction efforts
Lederman, J., Ballard, J., Njike, V. Y., Margolies, L. R., & Katz, D. L. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.07.010 · Cited by 26
Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease.
Rehring, T. F., Stolcpart, R. S., Sandhoff, B. G., Merenich, J., & Hollis, H. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.02.019 · Cited by 28
Drug Therapy for Prevention of Recurrent Myocardial Infarction
van der Elst, M. E., Buurma, H., Bouvy, M. L., & de Boer, A. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c450 · Cited by 26
Influence of sedentary behavior, physical activity, and cardiorespiratory fitness on the atherogenic index of plasma
Edwards, M. K., Blaha, M. J., & Loprinzi, P. D. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.10.014 · Cited by 26
The Role of E-Government Ambidexterity as the Impact of Current Technology and Public Value: An Empirical Study
Hariguna, T., Rahardja, U., & Sarmini (2022) · Informatics · doi:10.3390/informatics9030067 · Cited by 38
Identifying women with severe angiographic coronary disease
Kreatsoulas, C., Natarajan, M. K., Khatun, R., Velianou, J. L., & Anand, S. S. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02210.x · Cited by 25
Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature Review
Lavoie, L., Khoury, H., Welner, S. A., & Brière, J. (2016) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12180 · Cited by 25
Characteristics of people aged 45 years or older with heart disease by frequent mental distress status, 2001
Strine, T. W., Greenlund, K. J., Brown, D. W., Mokdad, A. H., & Balluz, L. S. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.01.022 · Cited by 25
Suboptimal use of statin therapy in elderly patients with atherosclerosis: A population-based study
Al-Omran, M. A., Mamdani, M., Lindsay, T. F., de Melo, M. N., Juurlink, D. N., & Verma, S. (2008) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.04.057 · Cited by 25
Modifications of Coronary Risk Factors
Albu, J., Gottlieb, S. H., August, P., Nesto, R. W., & Orchard, T. J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.03.012 · Cited by 24
Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX‐2 selective Inhibitor etoricoxib
Curtis, S., Ko, A. T., Bolognese, J. A., Cavanaugh, P. F., & Reicin, A. S. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x148238 · Cited by 25
Usefulness of Beta Blockade in Contemporary Management of Patients With Stable Coronary Heart Disease
Winchester, D. E., & Pepine, C. J. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.08.026 · Cited by 24
Nonadherence to clinical practice guidelines and medications for multiple chronic conditions in a California Medicaid population
Nichol, M. B., Knight, T. K., Priest, J. L., Wu, J., & Cantrell, C. R. (2010) · Journal of the American Pharmacists Association · doi:10.1331/japha.2010.09123 · Cited by 24
Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)—A randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events
Teramoto, T., Shimada, K., Uchiyama, S., Sugawara, M., Gotō, Y., Yamada, N., Oikawa, S., Ando, K., Ishizuka, N., Yamazaki, T., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2009.11.030 · Cited by 25
Atherosclerosis: Comparative Pathogenesis, Lipoprotein Metabolism, and Avian and Exotic Companion Mammal Models
Beaufrère, H. (2013) · Journal of Exotic Pet Medicine · doi:10.1053/j.jepm.2013.10.016 · Cited by 23
Statin Therapy, Fitness, and Mortality Risk in Middle-Aged Hypertensive Male Veterans
Kokkinos, P. F., Faselis, C. J., MYERS, J. N., Kokkinos, J., Doumas, M. N., Pittaras, A. E., Kheirbek, R., Manolis, A. J., Panagiotakos, D. B., Papademetriou, V., et al. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpt241 · Cited by 26
Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents
Kim, Y. H., Her, A., Jeong, M. H., Kim, B., Lee, S., Hong, S., Shin, D., Kim, J., Ko, Y., Choi, D., et al. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6841-7 · Cited by 24
Cyclic GMP Release by Acute Enhanced External Counterpulsation
Levenson, J. A., Pernollet, M.-G., Iliou, M. C., Devynck, M., & Simon, A. C. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.01.003 · Cited by 24
Use of β-Adrenoceptor Antagonists in Older Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Co-Morbidity
Andrus, M. R., & Loyed, J. V. (2008) · Drugs & Aging · doi:10.2165/00002512-200825020-00005 · Cited by 24
Pharmacologic management of ischemic stroke: Relevance to stem cell therapy
Gilman, S. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.03.002 · Cited by 24
Self-Reported Use of Complementary and Alternative Medicine in Patients With Previous Acute Coronary Syndrome
Decker, C., Huddleston, J., Kosiborod, M., Buchanan, D. M., Stoner, C. N., Jones, A., Banerjee, S., & Spertus, J. A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.041 · Cited by 23
Are patients receiving maximal medical therapy following carotid endarterectomy?
Betancourt, M., Stavern, R. V., Share, D. A., Gardella, P., Martus, M., & Chaturvedi, S. (2004) · Neurology · doi:10.1212/01.wnl.0000145841.96539.9b · Cited by 23

Authors: Smith, S. C., Blair, S. N., Bonow, R. O., Brass, L. M., Cerqueira, M. D., Dracup, K., Fuster, V., Gotto, A., Grundy, S. M., Miller, N. H., Jacobs, A., Jones, D., Krauss, R. M., Mosca, L., Ockene, I., Pasternak, R. C., Pearson, T., Pfeffer, M. A., Starke, R. D., & Taubert, K. A.
Affiliations: American Heart Association (US)
The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest., This statement was approved by the American Heart...
ORCID: Blair, Steven N.
Bonow, Robert O.
Gotto, Antonio
Grundy, Scott M.
Miller, Nancy Houston
Jacobs, Alice
Jones, Daniel
Krauss, Ronald M.
Pfeffer, Marc A.
Taubert, Kathryn A.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2001-09-25
Volume: 104
Issue: 13
Pages: 1577-1579
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/hc3801.097475
OpenAlex: W2913860186
Cited by: 661
References: 36
Citations by year: 2025: 1 · 2024: 2 · 2023: 6 · 2022: 8 · 2021: 2 · 2020: 2 · 2019: 8 · 2018: 6 · 2017: 5 · 2016: 14 · 2015: 16 · 2014: 18 · 2013: 22 · 2012: 20
FWCI: 60.69
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
eScholarship@UMassChan (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords: secondary prevention, atherosclerotic cardiovascular disease, cardiovascular risk management, myocardial infarction prevention, cardiovascular mortality, recurrent cardiovascular events, clinical trial evidence
MeSH terms: American Heart Association, Arteriosclerosis, Cardiovascular Diseases, Heart Arrest, Humans, Preventive Medicine, Rehabilitation, United States, Death, Sudden, Cardiac, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update: A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks